SCHEMBL20476348

SCHEMBL20476348

O=C(Cc1cccc(C2CCCC2)c1O)OC1CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HPGD P15428 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SLC6A2 P23975 7/20 0.40
SLC6A4 P31645 7/20 0.40
SLC6A3 Q01959 7/20 0.40
CYP19A1 P11511 2/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.38
NAAA Q02083 1/20 0.38
HTR1A P08908 3/20 0.38
HRH1 P35367 3/20 0.37
CYP2D6 P10635 1/20 0.37
KCNH2 Q12809 1/20 0.37
HTR2C P28335 2/20 0.36
MMP1 P03956 1/20 0.35
MMP9 P14780 1/20 0.35
MMP12 P39900 1/20 0.35
CHRM3 P20309 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1999955 0.93 SLC6A2 (0.40) KDM4EALDH1A1HPGDHSD17B10SLC6A2
SCHEMBL23358779 0.83 CHRM3 (0.41) KDM4EALDH1A1HPGDHSD17B10CYP19A1
SCHEMBL4186784 0.81 NAAA (0.39) KDM4EALDH1A1HPGDHSD17B10SLC6A2
SCHEMBL1707214 0.80 CHRM3 (0.42) KDM4EALDH1A1HPGDHSD17B10SLC6A4
SCHEMBL5473748 0.80 CHRM3 (0.42) KDM4EALDH1A1HPGDHSD17B10SLC6A4
SCHEMBL2340421 0.80 CHRM3 (0.42) KDM4EALDH1A1HPGDHSD17B10SLC6A4
SCHEMBL1697177 0.79 CHRM4 (0.44) ALDH1A1CYP2D6CHRM3
SCHEMBL4889902 0.79 ALDH1A1 (0.34) KDM4EALDH1A1HPGDHSD17B10CYP19A1
SCHEMBL7142072 0.79 CHRM3 (0.42) KDM4EALDH1A1HPGDHSD17B10SLC6A4
Bromide SCHEMBL1996228 0.79 CHRM3 (0.43) KDM4EALDH1A1HPGDHSD17B10SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018150347-A1 COMPOUNDS WITH BETA-ADRENERGIC AGONIST AND ANTIMUSCARINIC ACTIVITY TORRENT PHARMACEUTICALS LIMITED (IN) 2018-08-23 WO disclosed